The International Cancer Centre Abuja (ICCA), founded by the late President Umaru Musa Yar’Adua’s widow, Hajiya Turai Yar’Adua, has entered into a partnership with Singapore-based Innova Healthcare Nigeria Limited to establish a comprehensive oncology centre in Abuja.
The two organisations signed a Memorandum of Understanding (MoU) for the development of the centre at ICCA’s existing facility on Airport Road, Abuja.
The proposed facility is expected to provide cancer diagnosis and treatment services under one roof.
Services will include radiotherapy, chemotherapy, surgical oncology, diagnostics, laboratory services and palliative care.
Rather than constructing a new facility, the partnership will utilise ICCA’s existing building.
A statement by ICCA’s Communications Manager, Arhyel Shadrach Ayuba, said the agreement provides a framework for collaboration between both organisations and represents an important step towards achieving the vision of the centre’s founder.
Director-General of ICCA, Shehu Yar’Adua, said the partnership would bring the organisation closer to its objective of making quality cancer care accessible to Nigerians.
He said: “When our founder first envisioned this centre, she dreamed of a Nigeria where no one would have to travel abroad or go without care altogether to survive a cancer diagnosis.”
He added: “This partnership with Innova brings us a meaningful step closer to that dream, not by starting from scratch, but by building on the foundation she laid.”
Managing Director of Innova Healthcare Nigeria Limited, Francis Shokoya, said the company was committed to collaborating with healthcare facilities such as ICCA to make cancer treatment available and affordable.
Shokoya said the partnership was inspired by the commitment of ICCA’s founder to improving access to cancer care, particularly for vulnerable Nigerians.
He added that the collaboration would include training and capacity building for Nigerian clinical and technical personnel, as well as investment in modern equipment and infrastructure.
According to the statement, Nigeria continues to face a significant cancer burden, while access to radiotherapy and specialist oncology services remains inadequate compared with the country’s population.
The partnership is therefore expected to help bridge the gap by expanding access to comprehensive cancer treatment in the Federal Capital Territory.
ICCA was founded in 2009 by Hajiya Turai Yar’Adua with the vision of establishing a nationwide cancer centre capable of providing Nigerians with access to world-class diagnosis and treatment.
Innova Healthcare Nigeria Limited is a subsidiary of Singapore-based Innova Bio-Medical Pte Ltd, which specialises in comprehensive cancer treatment.
The company is also associated with Linatech, manufacturers of the Venus X cancer treatment machine, among other medical technologies.
© 2026, Standard Focus. All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from STANDARD FOCUS.